Press Release

Biological Skin Substitutes to dominate in the Global Skin Substitutes Market through 2028

Global Skin Substitutes Market is expected to be driven by the increasing prevalence of severe skin injuries in the forecast period.


According to TechSci Research report,
Skin Substitutes Market –Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Global Skin Substitutes Market is anticipated to grow at an impressive rate in the forecast period, 2024-2028. This can be attributed to the increasing number of developments happening in the global skin substitutes market such as the use of advanced materials, such as nanofibers and hydrogels, and the development of new manufacturing techniques that allow for the creation of products that are more consistent and reliable. These advances are likely to lead to the creation of products that are more effective in treating a wider range of skin injuries.


Besides, growing popularity of xenotransplantation is expected to create lucrative opportunities for the growth of global skin substitutes market, especially the biological substitutes, xenograft segment. However, lack of awareness pertaining to skin substitutes especially in the emerging countries can slow down the global skin substitutes market growth. Also, lack of skilled professionals who can use and perform procedures using skin substitutes can further restrict the growth of global skin substitutes market.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Skin Substitutes Market


Global Skin Substitutes Market can be segmented by type, by application, by end user, and by region. Based on type, global skin substitutes market can be divided into biological and synthetic. Biological skin substitute can be further categorized into autografts, allografts, and xenografts. Biological skin substitute market dominated the market in 2022 on account of their high success rate and low risk of rejection by the patient's body. However, synthetic skin substitutes are also expected to see significant growth in the coming years due to technological advancements in the field.


Autografts are skin substitutes that are taken from a patient's own body and transplanted onto the affected area. They are often used in cases where a patient has a small wound or injury, and there is enough healthy skin available to cover the affected area. Autografts have a very high success rate, as the body is less likely to reject the transplanted tissue. Allografts are skin substitutes that are taken from a donor, usually a cadaver. These substitutes are commonly used in the treatment of large burn injuries, as they can cover a larger area than autografts. However, there is a higher risk of rejection with allografts, as the tissue is not from the patient's own body. Xenografts are skin substitutes that are taken from a different species, usually a pig. These substitutes are often used in the treatment of large burn injuries or in cases where a patient has a weakened immune system. However, the risk of rejection with xenografts is very high, as the tissue is not from a human.


Regionally, the Asia Pacific region is expected to see significant growth in the coming years in the global skin substitute market due to increasing investment in healthcare infrastructure and rising awareness of advanced wound care products.


Major companies operating in the Global Skin Substitutes Market are:

  • Amarantus BioScience Holdings, Inc.
  • Organogenesis, Inc
  • Acelity L.P., Inc.
  • Smith & Nephew plc
  • BSN Medical GmbH
  • Molnlycke Health Care AB
  • Integra LifeSciences Corporation
  • Medtronic Plc
  • Tissue Regenix Ltd.
  • Stratatech Corporation


These companies are investing in research and development to develop new and innovative products to meet the growing demand for advanced wound care products. One recent product launch in the field of skin substitutes is Apligraf, a product developed by Organogenesis. Apligraf is a bilayered skin substitute that contains both living cells and a matrix of proteins that mimic the structure of the skin. This product is designed to treat chronic wounds, such as diabetic foot ulcers and venous leg ulcers, and has been shown to be highly effective in promoting healing and reducing the risk of infection. Apligraf was first approved by the FDA in 1998, and has since been used to treat millions of patients around the world.


Download Free Sample Report

Customers can also request for 10% free customization on this report.


“The global skin substitutes market has seen a number of exciting new product launches in recent years, as companies develop new and innovative products designed to improve the treatment of a range of skin injuries. These products are aimed at creating new solutions that are more effective, more versatile, and easier to use, and are likely to have a major impact on the future of the field. As the demand for effective skin substitutes continues to grow, it is clear that companies will continue to innovate and develop new products that can help improve patient outcomes and reduce the risk of complications, thereby creating prospects for the growth of global skin substitutes market.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.


Skin Substitutes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Type (Biological v/s Synthetic), By Application (Acute Wounds v/s Chronic Wounds), By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others), By Region and Competition
”, has evaluated the future growth potential of Global Skin Substitutes Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Skin Substitutes Market.


Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com